1995
DOI: 10.1111/j.1440-1681.1995.tb02930.x
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Gamma‐linolenic and Eicosapentaenoic Acids on Blood Pressure in SHR

Abstract: 1. The present study was performed to determine whether chronic treatments with gamma linolenic acid (n-6, GLA) or eicosapentaenoic acid (n-3, EPA) would alter serum and red blood cell (RBC) unsaturated fatty acid composition, and to determine whether these treatments would affect blood pressure (BP), serum lipid metabolism and the development of atherosclerosis in spontaneously hypertensive rats (SHR).2. To compare the effects on atherosclerosis, some SHR were denuded of aortic endothelium so that the develop… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
7
0

Year Published

1999
1999
2011
2011

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 8 publications
0
7
0
Order By: Relevance
“…It was found that in the adult SHR, DHA but not EPA reduced the vascular thromboxane-like vasoconstrictor responses in aortas after inhibition of nitric oxide with N -nitro-L-arginine. In contrast, Sasaki et al 18 showed that EPA, compared with ␥-linoleic acid, significantly reduced the rise in BP in 11-week-old SHRs.…”
Section: Discussionmentioning
confidence: 86%
See 1 more Smart Citation
“…It was found that in the adult SHR, DHA but not EPA reduced the vascular thromboxane-like vasoconstrictor responses in aortas after inhibition of nitric oxide with N -nitro-L-arginine. In contrast, Sasaki et al 18 showed that EPA, compared with ␥-linoleic acid, significantly reduced the rise in BP in 11-week-old SHRs.…”
Section: Discussionmentioning
confidence: 86%
“…16 Other studies have shown that dietary DHA prevented the development of hypertension in the stroke-prone SHR 17 and that EPA, compared with ␥-linoleic acid, reduced the elevation of BP in the SHR without affecting HR. 18 In contrast, in the only human study to date, EPA and DHA supplementation in healthy, nonsmoking men failed to show any difference between the 2 fatty acids or any change in BP. 19 Given the in vitro and in vivo data from animal studies that suggest that EPA and DHA may differ in their effects on BP and HR, we conducted a double-blind, randomized, placebocontrolled study to examine these possible differences in mildly hyperlipidemic men who are at increased risk of cardiovascular disease.…”
mentioning
confidence: 87%
“…More than a decade ago, LA was reported to inhibit platelet adhesion and aggregation by reducing the formation of the vasoactive eicosanoid thromboxane A 2 (TXA 2 ) [9]. Moreover, PGE, generated from dihomo-GLA, was demonstrated to exhibit anti-aggregatory, anti-inflammatory and antiproliferative effects [8,10]. Contradictory reports came from Bhadra et al [11] who showed that Cu +2 ion-induced peroxidation of lipoprotein cholesterol to oxysterols and aortic accumulation of lipid peroxides were significantly higher in rabbits fed corn oil compared to animals fed saturated fat and that the difference persisted even at 5 weeks after switching to chow diet.…”
Section: Introductionmentioning
confidence: 99%
“…The anti-atherogenic effects of UFAs may be attributed to their LDL-Clowering effects [6,14], to their anti-inflammatory effects on vascular cells [15] and to their antithrombotic effects [8][9][10]. The mechanisms of action of fatty acids are not completely understood and are complex because they are involved at various stages of cell biology, including membrane structure, cell metabolism, energy production and cell signaling.…”
Section: Introductionmentioning
confidence: 99%
“…Experiments using purified forms of the major components of these oils-EPA (20:5n-3) and DHA (22:6n-3)-have shown a decrease in blood pressure in patients suffering from hypertension (6) and in SHR (7,8). Contradictory reports show no protective effect of the consumption of fish oil-or of its derivatives-on hypertension (9)(10)(11), if used at low doses.…”
mentioning
confidence: 99%